To determine gender and age differences in the prevalence of depression and anxiety and their predictive factors in adult patients with type 1 diabetes (DM1).
Random sample of DM1 adult patients from a tertiary care hospital cohort. To evaluate the presence of depression and anxiety, psychological evaluation was performed using structured clinical interview (MINI). For the specific evaluation of fear of hypoglycemia (FH), FH-15 questionnaire was used.
339 patients [51.6% male; 38.5 ± 12.9 years; HbA1c 7.5 ± 1.1% (58.5 ± 14.2 mmol/mol); 20.1 ± 12.0 years of DM1] met the inclusion criteria. Prevalence of depression, anxiety, and FH in men vs. women was as follows (%): depression: 15.4 vs. 33.5 (p < 0.05); anxiety: 13.7 vs. 26.2 (p < 0.05); and FH: 42.8 vs. 46.0 (p = NS). Among midlife female patients, prevalence of depression and anxiety was higher compared to male. Moreover, comorbid depressive and anxious symptoms were also higher in midlife female patients compared to age-matched male patients (3.5 vs. 14%, p < 0.05). Apart from age-related vulnerability, female gender, poor glycemic control, and microvascular and macrovascular complications were predictive factors for depressive and anxious symptomatology. Unawareness hypoglycemia and anxiety-prone personality were predictor factors for FH.
In adults with DM1, prevalence of depression and anxiety is higher in women. Midlife patients, in particular women, show a significantly higher prevalence of anxiety symptoms and comorbid depression and anxiety. The presence of secondary complications and sustained poor glycemic control should alert to the possibility of these mental disorders, especially in the most vulnerable age population; clinical, gender and age-related patterns could help to design more effective psychological assessment and support in adult patients with DM1.
Mental disorders (2017) http://www.who.int/mediacentre/factsheets/fs396/en/. Accessed 3 Oct 2017
Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge
(2017) Investing in treatment for depression and anxiety leads to fourfold return. http://www.who.int/mediacentre/news/releases/2016/depression-anxiety-treatment/en/. Accessed 3 Oct 2017
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:434–442 CrossRef
Abrahamian H, Kautzky-Willer A, Rießland-Seifert A, Fasching P, Ebenbichler C, Hofmann P et al (2016) Mental disorders and diabetes mellitus. Wien Klin Wochenschr 128:170–178 CrossRef
Diabetes management guidelines (2017) http://www.ndei.org/ADA-diabetes-management-guidelines-children-adolescents-type-1-diabetes-type-2-diabetes.aspx.html. Accessed 3 Oct 2017
Lloyd CE, Roy T, Nouwen A et al (2012) Epidemiology of depression in diabetes: international and cross-cultural issues. J Affect Disord 142:S22–S29 CrossRef
American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care 37:S14–S80 CrossRef
Sheehan DV, Lecrubier Y, Sheehan KH et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33 PubMed
Soto M, Bobes J, Soto O et al. MINI Entrevista Neuropsiquiátrica Internacional http://www.academia.cat/files/425-7297-DOCUMENT/MinientrevistaNeuropsiquatribaInternacional.pdf. Accessed 16 Apr 2018
Frances A (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association
Carreira M, Anarte MT, Ruiz De Adana MS et al (2010) Depression in type 1 diabetes mellitus and associated factors. Med Clin (Barc) 135:151–155 CrossRef
Lloyd CE, Nouwen A, Sartorius N et al. (2018) Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med. https://doi.org/10.1111/dme.13611 CrossRefPubMed
Afifi M (2007) Gender differences in mental health. Singapore Med 48:385–391
Aguilar Figueroa VD, Morales Carmona F (1995) Ansiedad y autoconcepto en pacientes embarazadas diabéticas. Perinatol Reprod Hum 9:99–105
López MEG, Calva EA (2013) Alteraciones psicológicas en la mujer con embarazo de alto riesgo. Psicología y Salud 17:53–61
Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat 19:113–122